Research Grants show all

NIH18

Publications show all

PaxVax has published 21 articles.

Patents show all

PaxVax has 1 licensable patents.
15Applications6Issued

Clinical Trials show all

6Phase 13Phase 31N/A1Phase 21Phase 4

SEC Filings show all

D6

SEC Form D Funding Events

DateOfferedSoldType
2014-08-11$35,479,182$34,929,181Equity, Other
2014-04-18$15,000,000$6,000,000Debt
2013-10-31$3,000,000$2,500,000Debt, Other
2013-10-01$35,106,472$35,106,472Debt, Option to Acquire, Security to be Acquired, Other
2009-11-06$6,000,000$2,000,000Equity, Debt, Option to Acquire
2007-06-01UnknownUnknownOther (Paper Filing)

Key Executives

  • Kenneth J. Kelley
    Executive Officer, Director
  • Rennie Coit
    Director
  • Howard B. Rosen
    Director
  • Richard Tong
    Director
  • Janine M. Taylor
    Executive Officer
  • Henry G. Coit, Jr.
    Director
  • Phil Russell
    Director
  • James Connolly
    Director